¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"active amino acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • uric acid infarct
    ¿ä»ê°æ»ö
  • uric acid nephropathy
    ¿ä»ê¿°ÄáÆÏº´(Áõ), ¿ä»ê¿°½ÅÀ庴(Áõ)
  • uric acid stone
    ¿ä»êµ¹
  • uridine diphosphate glucuronic acid
    ÀÌÀλê¿ì¸®µò±Û·çÄí·Ð»ê
  • urocanic acid
    ¿ì·ÎÄ­»ê
  • uronic acid
    ¿ì·Ð»ê
  • ursodeoxycholic acid
    ¿ì¸£¼Òµ¥¿Á½ÃÄÝ»ê
  • volatile acid
    Èֹ߼º»ê
  • valproic acid
    ¹ßÇÁ·Î»ê
  • vanillylmandelic acid
    ¹Ù´Ò¸±¸¸µ¨»ê
  • xanthurenic acid
    Å©»êÅõ·»»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • indoxyl carbonic acid ester
    Àε¶½Çź»ê¿¡½ºÅ׸£
  • inosinic acid
    À̳ë½Å»ê.
  • phocenic acid
    ±æÃÊ»ê(ÑÎõ³ß«).
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇǺ긣»ê.
  • phosphotungstic acid hematoxylin =ptah
    ÀÎ(ìÝ)ÅÖ½ºÅÙ»êÇ츶Åå½Ç¸°
  • picramic acid
    ÇÇÅ©¶÷»ê(¡­ß«).
  • polyunsaturate fatty acid
    ´Ù(Òý)ºÒÆ÷È­Áö¹æ»ê.
  • propionic acid
    ÇÁ·ÎÇǿ»ê(¡­ß«).
  • prostatic acid phosphatase
    Àü¸³¼±»êÀλêÈ¿¼Ò(Æ÷½ºÆÄŸÁ¦)(îñí¡àÍß«×òß«ý£áÈ)
  • pteroylmonoglutamic acid
    Å×·ÎÀϸð³ë±Û·çŽ»ê(¡­ß«)
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê(¡­ß«).
  • pyroligneous acid
    ¸ñÃÊ»ê(ÙÊõ³ß«).
  • pyrophosphoric acid
    ÇÇ·ÎÀλê(¡­ìÝß«).
  • pyrosulfuric acid
    ÇÇ·ÎȲ»ê(¡­üÜß«).
  • pyrotartarid acid
    ÇǷΟ¸£Å¸¸£»ê(¡­ß«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • desoxyribonucleic acid =DNA
    µ¥¿Á½Ã¸®º¸ÇÙ»ê(¡­ú·ß«).
  • diacetic acid
    ÀÌÃÊ»ê
  • dibasic acid
    ÀÌ¿°±â»ê(ì£ç¤Ðñß«).
  • dicarboxylic acid
    µðÄ«¸£º¹½Ç»ê.
  • dilute acid
    ¹±Àº »ê(¡­ß«).
  • dipicolinic acid
    µðÇÇÄݸ°»ê
  • essential fatty acid
    Çʼö(ù±âÎ)Áö¹æ»ê(ò·Û¸ß«)
  • ethacrynic acid
    ¿¡Å¸Å©¸°»ê.
  • ethylenedia mintetraacetic acid =EDTA
    ¿¡Æ¿·»µð¾Æ¹Î »ç-¾Æ¼¼Æ®»ê.
  • ethylenediamine tetraacetic acid
    ¿¡Æ¿·»µð¾Æ¹Î»ç-¾Æ¼¼Æ®»ê
  • ethylenediaminetetraacetic acid
    ¿¡Æ¿·»µð¾Æ¹Î »ç¾Æ¼¼Æ®»ê
  • fatty acid
    Áö¹æ»ê(¡­ß«)
  • fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • fatty acid =FA
    Áö¹æ»ê(ò·Û¸ß«).
  • fibril acid
    ¼¶À¯»ê(àéë«ß«).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • gamma aminobutyric acid
    °·¸¶ ¾Æ¹Ì³ëºêƼ¸£»ê(ß«)
  • general acid-base catalysis
    ÀϹÝ(ìéÚõ) »ê-¿°±â Ã˸Å(ß«-ç¤ÐñõºØÚ)ÀÛ¿ë
  • gibberellic acid
    Áö¹ö·¼¸°»ê(ß«)
  • glucuronic acid
    ±Û·çÅ¥·Ð»ê(ß«)
  • glucuronic acid oxidation pathway
    ±Û·çÅ¥·Ð»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • glutamic acid
    ±Û·çŽ»ê(ß«)
  • glutaric acid
    ±Û·çŸ¸£»ê(ß«)
  • glycaric acid
    ±Û¶óÀÌÄ«¸£»ê(ß«)
  • glycerophosphoric acid
    ±Û¸®¼¼·ÎÀλê(×òß«)
  • glycocholic acid
    ±Û¶óÀÌÄÚÄÝ»ê(ß«)
  • glycolic acid cycle
    ±Û¶óÀÌÄÝ»ê(ß«) ȸ·Î(üÞÖØ)
  • glyconic acid
    ´ç»ê(ÓØß«)
  • glycuronic acid
    ±Û¶óÀÌÅ¥·Ð»ê(ß«)
  • glycyrrhizinic acid
    ±Û¶óÀ̽ø®Áø»ê(ß«)
  • glyoxylic acid reaction
    ±Û¶óÀÌ¿Á½Ç»ê(ß«) ¹ÝÀÀ(Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
NAAP N-acetyl-4-amino-phenazone
Nt amino terminal
OKT ornithine ketoacid amino-transferase
TAGH triiodothyronine, amino acids, glucagon, and heparin
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
HAART Highly Active Antiretroviral Therapies
HAART Highly active antiretroviral treatment
PAR Photosynthetically Active Radiation
SAPL Surface-active phospholipid
TANs Tonically Active Neurons
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • xylic acid
    ÀÚÀϸ°[Å©½Ç]»ê
    °áÁ¤»ê.
  • zinc oxide-ethoxybenzoic acid cement
    EBA ½Ã¸àÆ®
    »êÈ­ ¾Æ¿¬ À¯Áö³î ½Ã¸àÆ®ÀÇ ¾×Áß¿¡¼­ À¯Áö³îÀÇ ´ëºÎºÐÀ» EBA·Î ´ëüÇÑ Ä¡°ú¿ë ½Ã¸àÆ®.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
alpha-ketoglutaramic acid H2N-COCH2CH2COCOOH;a metabolite of glutamine formed by the action of glutamine aminotransferase; elevated in certain cases of hepatocoma.
Synonym: 2-oxoglutaric acid.
(05 Mar 2000)
alpha-ketosuccinamic acid NH2-CO-CH2-CO-COOH;the transamination product of asparagine; acted upon by ω-amidase.
(05 Mar 2000)
alpha-linolenic acid <chemical> (z,z,z)-9,12,15-octadecatrienoic acid. A fatty acid that is found in plants and involved in the formation of prostaglandins.
Chemical name: 9,12,15-Octadecatrienoic acid, (Z,Z,Z)-
(12 Dec 1998)
alpha-(N-acetylaminomethylene)succinic acid hydrolase <enzyme> Involved in degradation of vitamin b6; forms acetic acid plus ammonia plus carbon dioxide plus succinic monoaldehyde
Registry number: EC 3.5.1.-
Synonym: compound a hydrolase
(26 Jun 1999)
alpha-N-acylamino acid hydrolase <enzyme> Functions in catabolism of n-acetylamino acids resulting from turnover of alpha-n-acetylated proteins
Registry number: EC 3.5.1.-
Synonym: alpha-n-acetylamino acid hydrolase, anaa-hase, n-acylaminoacyl-peptide hydrolase
(26 Jun 1999)
Altmann's anilin-acid fuchsin stain <technique> A mixture of picric acid, anilin, and acid fuchsin which stains mitochondria crimson against a yellow background.
(05 Mar 2000)
ametriodinic acid <chemical> 3-acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid. An ionic monomeric contrast medium.
Pharmacological action: contrast media.
Chemical name: Benzoic acid, 3-(acetylamino)-5-((acetylamino)methyl)-2,4,6-triiodo-
(12 Dec 1998)
aminoacetic acid <amino acid, physiology> The simplest amino acid. It is a common residue in proteins, especially collagen and elastin and is not optically active.
It is also a major inhibitory neurotransmitter in spinal cord and brainstem of vertebrate central nervous system.
(18 Nov 1997)
aminocaproic acid <chemistry> A group of compounds that are derivatives of aminohexanoic acids.
<haematology> An antifibrinolytic agent, used to prevent bleeding in haemophilia, and after heart and prostate surgery when plasminogen or urokinase may be activated.
(05 Mar 2000)
aminocarboxylic acid <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms.
There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA.
All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains.
There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins.
Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation.
Acronym: AA
(13 Nov 1997)
aminocitric acid HOOCCH(NH3+)C(COOH)(OH)CH2CO; OH;found in acid hydrolysates of ribonucleoprotein in human spleen.
(05 Mar 2000)
aminoethanoic acid <amino acid, physiology> The simplest amino acid. It is a common residue in proteins, especially collagen and elastin and is not optically active.
It is also a major inhibitory neurotransmitter in spinal cord and brainstem of vertebrate central nervous system.
(18 Nov 1997)
aminoethylphosphonic acid <chemical> (2-aminoethyl)-phosphonic acid. An organophosphorus compound isolated from human and animal tissues.
Chemical name: Phosphonic acid, (2-aminoethyl)-
(12 Dec 1998)
aminolevulinic acid <chemical> Chemical name: Pentanoic acid, 5-amino-4-oxo-
(12 Dec 1998)
aminooxyacetic acid <chemical> (aminooxy)acetic acid. A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.
Pharmacological action: enzyme inhibitors, gaba agents.
Chemical name: Acetic acid, (aminooxy)-
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á